AXGN
- AxoGen, Inc.
()
Overview
Company Summary
AxoGen, Inc. is a medical technology company that focuses on the development and commercialization of innovative surgical solutions for peripheral nerve injuries. The company is dedicated to improving the outcomes of patients suffering from nerve injuries by providing advanced products and technologies to surgeons.
AxoGen's core product offering is called Avance� Nerve Graft, which is a processed human nerve graft that is used to bridge nerve gaps and restore nerve function. This product is derived from human tissue sources and is processed to remove cellular and non-cellular components, leaving behind a nerve scaffold that supports nerve regeneration.
In addition to nerve grafts, AxoGen produces several other products that aid in nerve repair surgeries. These include AxoGuard� Nerve Connector, which is a porcine submucosa extracellular matrix (ECM) that acts as a protective covering for the nerve repair site, and AxoGuard� Nerve Protector, which is also a porcine submucosa ECM used to wrap and protect nerve reconstruction sites.
AxoGen's products are specifically designed to address the challenges associated with nerve injuries, such as nerve gaps, and provide surgeons with effective solutions for repairing damaged nerves. By offering a comprehensive portfolio of nerve repair products, AxoGen aims to improve the quality of life for patients who have experienced peripheral nerve injuries.